Citation Impact
Citing Papers
Seroepidemiology of toxoplasmosis in primigravida women in Hamadan, Islamic Republic of Iran, 2004.
2008
Rodent-borne diseases and their risks for public health
2009 Standout
Development of a leishmaniasis vaccine: the importance of MPL
2003
Origins and evolution of the Western diet: health implications for the 21st century1,2
2005 Standout
Cutaneous Leishmaniasis: Recent Developments in Diagnosis and Management
2015
Leishmaniasis
2018 Standout
Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis
2009
Neglected tropical diseases
2009 Standout
Toxoplasma gondii infection in humans and animals in the United States
2008 Standout
The Predictive Validity of Naturally Acquired Delayed‐Type Hypersensitivity to Leishmanin in Resistance toLeishmania major–Associated Cutaneous Leishmaniasis
2005
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
2008 Standout
Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
2009 Standout
Immunologic memory in cutaneous leishmaniasis
2005
Chapter 2 Fasciola, Lymnaeids and Human Fascioliasis, with a Global Overview on Disease Transmission, Epidemiology, Evolutionary Genetics, Molecular Epidemiology and Control
2009 Standout
Case study for a vaccine against leishmaniasis
2013
Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
2014
The immunology of susceptibility and resistance to Leishmania major in mice
2002 Standout
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial
2007
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
From the discovery of the Malta fever?s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis
2005 Standout
Leishmaniavaccines: progress and problems
2006
Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis
2008
The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and Elimination
2008 Standout
Cutaneous leishmaniasis
2007 Standout
Development of a recombinant Leishmania major strain sensitive to ganciclovir and 5-fluorocytosine for use as a live vaccine challenge in clinical trials
2004
Risk factors in transmission of brucellosis from animals to humans in Saudi Arabia
1992
Analysis of Granzyme B Activity as a Surrogate Marker ofLeishmania‐Specific Cell‐Mediated Cytotoxicity in Zoonotic Cutaneous Leishmaniasis
2004
Second-generation vaccines against leishmaniasis
2005
Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran
2004
Consort 2010 statement: extension to cluster randomised trials
2012 Standout
Effective clearance of intracellular Leishmania majorin vivo requires Pten in macrophages
2008 StandoutNobel
Molecular biology of the Bunyaviridae
1990 Standout
Domestic dog ownership in Iran is a risk factor for human infection with Leishmania infantum.
2002
An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine
2001
Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia
2005
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan
2000
Cutaneous Leishmaniasis in Travellers: a Focus on Epidemiology and Treatment in 2015
2015
Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of .
2005
Toward a Causal Model of Cardiovascular Responses to Stress and the Development of Cardiovascular Disease
2003
The methodological quality of cluster randomised controlled trials for managing tropical parasitic disease: a review of trials published from 1998 to 2007
2009
Leishmaniasis Worldwide and Global Estimates of Its Incidence
2012 Standout
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
2008 Standout
Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matchedcluster randomised trial
2002
LeishVet guidelines for the practical management of canine leishmaniosis
2011 Standout
The Prevalence and Source of Toxoplasma Infection in the Environment
1989
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
Constructive and unconstructive repetitive thought.
2008 Standout
Toxoplasma gondii: from animals to humans
2000 Standout
Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis
2002
Sex differences in immune responses
2016 Standout
Liposomes as nanomedical devices
2015 Standout
2006
Complications Associated with Brucella melitensis Infection: A Study of 530 Cases
1996 Standout
Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria
2006 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Recent advances in vaccines for leishmaniasis
2004
The leishmaniases as emerging and reemerging zoonoses
2000
Photodynamic therapy for localized infections—State of the art
2009 Standout
CLINICAL PICTURE OF CUTANEOUS LEISHMANIASIS IN ISFAHAN, IRAN
1994
Control of Neglected Tropical Diseases
2007 Standout
Fascioliasis and other plant-borne trematode zoonoses
2005 Standout
Further evidence that deltamethrin‐impregnated collars protect domestic dogs from sandfly bites
2000
Leishmaniasis
1999 Standout
Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis
2005
A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran
1999
Seroprevalence of anti-Toxoplasma gondii antibodies in buffaloes in Khoozestan province, Iran
1998
LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014
2013
Sero-Prevalence ofToxoplasmainfection in human and dog population in Shiraz, Iran
1993
Development and Assessment of Loop-Mediated Isothermal Amplification (LAMP) Assay for the Diagnosis of Human Visceral Leishmaniasis in Iran.
2014
Cutaneous leishmaniasis – Authors' reply
2008 Standout
Surface antigens of Leishmania donovani promastigotes.
1983
Prevalência de hipertensão arterial sistêmica e fatores associados na região urbana de Porto Alegre : estudo de base populacional
1994 Standout
Epidemiology of the Leishmaniases
1995
Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature
2016
Evidence suggesting that Fasciola gigantica might be the most prevalent causal agent of fascioliasis in northern Iran
2016
Functional Anatomy, Pathomechanics, and Pathophysiology of Lateral Ankle Instability.
2002 Standout
The Genus Phlebovirus and its Vectors
1988
Interventions for American cutaneous and mucocutaneous leishmaniasis
2009
Vervet Monkeys Vaccinated with KilledLeishmania majorParasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected against Challenge Infection
2001
Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994-95.
1998
Sex-Associated Hormones and Immunity to Protozoan Parasites
2001
Leishmaniasis: current situation and new perspectives
2004 Standout
Treatment of Cutaneous Leishmaniasis With Itraconazole
1996
Fumo, bebida alcoólica, migração, instrução, ocupação, agregação familiar e pressão arterial em Volta Redonda, Rio de Janeiro
1985
Field evaluation of latex agglutination test for detecting urinary antigens in visceral leishmaniasis in Sudan
2003
Interventions for Old World cutaneous leishmaniasis
2008
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
The Potency and Durability of DNA- and Protein-Based Vaccines Against Leishmania major Evaluated Using Low-Dose, Intradermal Challenge
2001
Causes and consequences of higher Leishmania infantum burden in patients with kala‐azar: a study of 625 patients
2017
Advances in leishmaniasis
2005 Standout
Zanvil Alexander Cohn 1926-1993.
1994 StandoutNobel
A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivo
2007 StandoutNobel
LiveLeishmaniapromastigotes can directly activate primary human natural killer cells to produce interferon-gamma
2003
Brucellosis in a Group of Travelers to Spain
1984
Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease
2002
Characterization ofLeishmania donovaniAntigens Encapsulated in Liposomes That Induce Protective Immunity in BALB/c Mice
2002
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
A review of toxoplasmosis in cattle
1986
Immune responses in kala-azar.
2006
Leishmaniasis: Current Status of Vaccine Development
2001
Salt Consumption in Ancient Polynesia
1992
FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
2008
Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control
2006 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Interventions for Old World cutaneous leishmaniasis
2017
Meriones Iibycus and Rhombomys opimus (Rodentia: Gerbillidae) are the main reservoir hosts in a new focus of zoonotic cutaneous leishmaniasis in Iran
1996
Works of A Nadim being referenced
Epidemiological aspects of kala-azar in Meshkin-Shahr, Iran: human infection.
1993
Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran
2007
Leishmaniasis recidivans among school children in Bam, South‐east Iran, 1994–2006
2010
Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran
1998
Visceral leishmaniasis of jackals and dogs in northern Iran
1982
The epidemiology of cutaneous leishmaniasis in the Isfahan province of Iran
1968
Animal toxoplasmosis in Iran.
1983
Application of direct agglutination test (DAT) for the diagnosis and seroepidemiological studies of visceral leishmaniasis in Iran
2016
Epidemiology of human brucellosis in Isfahan, Iran
1974
Deltamethrin-impregnated bed nets and curtains in an anthroponotic cutaneous leishmaniasis control program in northeastern Iran
2007
Epidemiology of cutaneous leishmaniasis in Iran. B. Khorassan area. I. The reservoirs.
1968
Epidemiology of cutaneous leishmaniasis in the Isfahan province of Iran
1968
Deltamethrin-impregnated bed nets and curtains in an anthroponotic cutaneous leishmaniasis control program in northeastern Iran
2007
Blood Pressure and Rural-Urban Migration in Iran
1978
Application of the indirect fluorescent antibody test in the serodiagnosis of cutaneous and visceral leishmaniasis in Iran
1981
Present Status of Kala-Azar in Iran
1978
"EPIDEMIOLOGICAL ASPECTS OF KALA- AZAR IN MESHKIN SHAR, IRAN: INVESTIGATION ON VECTORS"
1992
Epidemiology of cutaneous leishmaniasis in Turkemen Sahara, Iran.
1968
Studies on the Epidemiology of Sandfly Fever in Iran
1977